Pei Zhu

640 total citations
46 papers, 396 citations indexed

About

Pei Zhu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pei Zhu has authored 46 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pei Zhu's work include Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Acute Myocardial Infarction Research (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Pei Zhu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Acute Myocardial Infarction Research (13 papers) and Lipoproteins and Cardiovascular Health (8 papers). Pei Zhu collaborates with scholars based in China, Netherlands and United States. Pei Zhu's co-authors include Xiaofang Tang, Yuejin Yang, Jinqing Yuan, Jingjing Xu, Bo Xu, Xueyan Zhao, Peter R. Allegrini, Deshan Yuan, Ying Song and David Simper and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Cardiovascular Research.

In The Last Decade

Pei Zhu

45 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei Zhu China 12 162 92 79 77 67 46 396
Rika Araki Japan 11 214 1.3× 97 1.1× 104 1.3× 123 1.6× 64 1.0× 19 459
Sanne Bøjet Larsen Denmark 13 174 1.1× 58 0.6× 90 1.1× 46 0.6× 57 0.9× 24 382
Manabu Uematsu Japan 14 163 1.0× 68 0.7× 106 1.3× 45 0.6× 43 0.6× 52 396
Shengjue Xiao China 10 108 0.7× 74 0.8× 63 0.8× 38 0.5× 76 1.1× 30 345
Zhenjun Ji China 11 128 0.8× 164 1.8× 78 1.0× 25 0.3× 53 0.8× 42 422
Xiaosong Ding China 12 270 1.7× 114 1.2× 87 1.1× 155 2.0× 118 1.8× 29 543
Takayuki Sugai Japan 9 102 0.6× 99 1.1× 72 0.9× 31 0.4× 61 0.9× 16 312
Marco Antonio Peña‐Duque Mexico 12 172 1.1× 83 0.9× 105 1.3× 40 0.5× 45 0.7× 51 389
Taku Toshima Japan 7 106 0.7× 86 0.9× 69 0.9× 31 0.4× 57 0.9× 16 297

Countries citing papers authored by Pei Zhu

Since Specialization
Citations

This map shows the geographic impact of Pei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Zhu more than expected).

Fields of papers citing papers by Pei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Zhu. The network helps show where Pei Zhu may publish in the future.

Co-authorship network of co-authors of Pei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Zhu. A scholar is included among the top collaborators of Pei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Zhu. Pei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ce, Jingjing Xu, Zhenyu Liu, et al.. (2024). The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study. BMC Medicine. 22(1). 599–599. 5 indexed citations
2.
Zhang, Kexin, Jiawen Li, Yu‐Long Li, et al.. (2024). Elevated High-Sensitivity C-Reactive Protein Level Enhances the Impact of Lipoprotein(a) on Platelet Reactivity in PCI Patients Treated with Clopidogrel. Clinical and Applied Thrombosis/Hemostasis. 30. 3005462215–3005462215. 1 indexed citations
3.
4.
5.
Zhu, Pei, Xiaofang Tang, Yulong Li, et al.. (2023). Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World. Journal of Atherosclerosis and Thrombosis. 30(8). 1057–1069. 2 indexed citations
6.
Deng, Cong, Tiansheng Zeng, Pei Zhu, et al.. (2023). A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 149(12). 10015–10025. 2 indexed citations
7.
Li, Jiawen, Pei Zhu, Jingjing Xu, et al.. (2023). Association between multiple inflammatory biomarkers and remnant cholesterol levels in patients with percutaneous coronary intervention: A large-scale real-world study. Nutrition Metabolism and Cardiovascular Diseases. 34(2). 377–386. 6 indexed citations
8.
Zhang, Zhiyong, Cong Deng, Pei Zhu, et al.. (2023). Single‐cell RNA‐seq reveals a microenvironment and an exhaustion state of T/NK cells in acute myeloid leukemia. Cancer Science. 114(10). 3873–3883. 12 indexed citations
9.
Song, Ying, Zheng Zhang, Jingjing Xu, et al.. (2023). Stress hyperglycemia ratio and long‐term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study. Journal of Diabetes. 15(7). 557–568. 22 indexed citations
10.
Li, Jiawen, Pei Zhu, Xiaofang Tang, et al.. (2023). Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China. iScience. 26(7). 107030–107030. 3 indexed citations
11.
12.
Liu, Ru, Deshan Yuan, Xiaofang Tang, et al.. (2022). Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention. Journal of International Medical Research. 50(4). 3629142653–3629142653. 3 indexed citations
13.
14.
Zhao, Xueyan, Jianxin Li, Pei Zhu, et al.. (2021). LONG-TERM FOLLOW-UP OUTCOMES OF DAPT SCORE: A LARGE-SAMPLE REAL WORLD STUDY FROM CHINA. Journal of the American College of Cardiology. 77(18). 113–113.
15.
Zhao, Xueyan, Jiawen Li, Fangchao Liu, et al.. (2021). The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China. European Heart Journal - Quality of Care and Clinical Outcomes. 8(8). 812–820. 12 indexed citations
16.
Dai, Yifeng, Zhiheng Cheng, Hongyou Zhao, et al.. (2021). Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 25(3). 1456–1467. 5 indexed citations
17.
Yuan, Deshan, Sida Jia, Pei Zhu, et al.. (2021). Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study. Frontiers in Endocrinology. 12. 700349–700349. 13 indexed citations
18.
Zhu, Pei, Zhan Gao, Xiaofang Tang, et al.. (2017). Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention. Chinese Medical Journal. 130(24). 2899–2905. 14 indexed citations
19.
Xue, Qi, et al.. (2016). Long noncoding RNA PVT1, a novel promising biomarker to predict lymph node metastasis and prognosis: a meta-analysis.. PubMed. 58(2). 160–6. 15 indexed citations
20.
Zhu, Pei, Qingqing Pan, Mengzhao Wang, Wei Zhong, & Jing Zhao. (2015). Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma. Thoracic Cancer. 6(6). 709–714. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rika Araki Breakdown of academic impact, for papers by Sanne Bøjet Larsen Breakdown of academic impact, for papers by Manabu Uematsu Breakdown of academic impact, for papers by Shengjue Xiao Breakdown of academic impact, for papers by Zhenjun Ji Breakdown of academic impact, for papers by Xiaosong Ding Breakdown of academic impact, for papers by Takayuki Sugai Breakdown of academic impact, for papers by Marco Antonio Peña‐Duque Breakdown of academic impact, for papers by Taku Toshima
Rankless by CCL
2026